JAMA • 2020.02.11
Tong S.Y.C., Lye D.C., Yahav D., Sud A., Robinson J.O., Nelson J., Archuleta S., Roberts M.A., Cass A., Paterson D.L., Foo H., Paul M., Guy S.D:, Tramontana A.R., Walls G.B., McBride S., Bak S., Ghosh N., Rogers B.A., Ralph A.P., Davies J., Ferguson P.E., Dotel r., McKew G.L., Gray T.L., Holmes N.E., Smith S., Warner M.S., Kalimuddin S., Young B.E., Runnegar N., Andresen D.N., Anagnostou N.A., Johnson S.A., Chatfield M.D., Cheng A.C., Fowler V.G. Jr, Howden B.P., Meagher N., Price D.J., van Hal S.J., O'Sullivan M.V.N., Davis J.S., Australasian Society for Infectious Diseases Clinical Research Network
- Clinical trial
- International
- Bacteremia, beta-lactams, Cefazolin, Clinical trial, Cloxacillin, Daptomycin, Floxacillin, MRSA, Vancomycin
Science • 2020.01.10
Liu J., Gefen O., Ronin I., et al.
- Bacterial mechanisms
- International
- Daptomycin, Drug therapy, MRSA, Pharmacology, Rifampicin, Tolerance, Vancomycin
PLOS One • 2021.10.20
Miller C.R., Monk J.M., Szubin R., et al.
Antibiotics • 2022.04.19
Jahan N.; Patton T.; O’Keeffe M.